Different Doses of Belantamab Mafodotin

Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Class Refractory Multiple Myeloma

Arms / Cohorts

Active Comparator:Group I: Low Dose Belantamab Mafodotin

Accepting patients

Experimental:Group II: Low Dose and High Dose Belantamab Mafodotin

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.